2000 Cannabinoids Clinical Trials 
Project CBD
NOVEMBER 11, 2023
He is the author of several bestselling books, including Spontaneous Healing (1995), Eating Well for Optimum Health (2000), and Healthy Aging (2007). We rate levels of evidence, and a high level may be a controlled randomized clinical trial (RCT), but there are also observational studies. How do you standardize for that?
CannaMD
NOVEMBER 15, 2020
research funders, the National Institute on Drug Abuse (NIDA) , spent over $1 billion between 2000 and 2008, with a heavily slanted focus on cannabis abuse and misuse, as well as the negative effects of cannabis. Non-profit organizations like the Canadian Consortium for Investigation of Cannabinoids (CCIC) were also formed to do research.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Otherside Farms
APRIL 30, 2019
Over 700 years later, between 2000 and 1000 BC, cannabis was noted in many Hindu and other religious texts in the area as a “source of happiness” and smoked in daily religious ceremonies and rituals. Fast forward over 2000 years to 1992. This is known as the Endocannabinoid system and every human is born with it.
Cannabis Law Report
JANUARY 4, 2022
Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, has named Simon Allen as Chief Executive Officer and a member of the company’s Board of Directors, effective February 1 st , 2022. and Australia.
Puff Puff Post
DECEMBER 28, 2018
With so many people affected by autism and incidence rates having increased by 119% between the years 2000 to 2010, it has gained the status of the quickest-growing developmental disability. The cannabinoids were administered in two different formulations, both of which had a ratio of 20:1 for CBD to THC. What Exactly is Autism ?
Cannabis Law Report
NOVEMBER 24, 2021
Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. 2016 ; Sznitman et al. years (Atakan 2012 ).
The Cannigma
OCTOBER 27, 2021
These findings were unearthed in a study titled “Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys,” carried out at the Mason Research Institute in Worcester Massachusetts in 1973. The monkeys were given caring doses of isolated cannabinoids ranging 131.3-3150 The bad news?
Expert insights. Personalized for you.
308 
Let's personalize your content